Lijian Wang
Sar, 999078, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A miniaturized-tumor culture platform for developing anti-tumor immunotherapies.
Journal: Theranostics
Published: January 26, 2026
Micro-Organ Chip Deciphers Tumor-Derived G-CSF as Remote Commander of Lung Pre-Metastatic Niche via VEGFA-KDR Cascade.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 22, 2025
RAD51B-EZH2 axis as a potential therapeutic target for TNBC through cell fate conversion.
Journal: Cell death & disease
Published: May 10, 2025
Suppressing protein damage response to overcome multidrug resistance in cancer therapy.
Journal: Cell discovery
Published: February 04, 2025
The heterogeneity of signaling pathways and drug responses in intrahepatic cholangiocarcinoma with distinct genetic mutations.
Journal: Cell death & disease
Published: May 14, 2023
Cullin-5 deficiency orchestrates the tumor microenvironment to promote mammary tumor development through CREB1-CCL2 signaling.
Journal: Science advances
Published: January 20, 2023
SB Digestor: a tailored driver gene identification tool for dissecting heterogeneous Sleeping Beauty transposon-induced tumors.
Journal: International journal of biological sciences
Published: November 28, 2022
Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast Cancer.
Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 23, 2021
NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation.
NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation.
Journal: Nature communications
Published: June 11, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026